Form 4 Filing for Anixa Biosciences Inc.

This filing details a transaction by Amit Kumar, the Chief Executive Officer and Director of Anixa Biosciences Inc. On June 12, 2026, Kumar acquired 21,000 shares of Common Stock at a price of $2.50 per share. Following this transaction, Kumar owns 630,812 shares of the company's stock. The transaction was reported on a Form 4, indicating a change in ownership. The filing also notes that Amit Kumar is an officer and director of the company, and not a ten percent owner.